We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
+35.97%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
AUM
$392M
AUM Growth
+$211M
Cap. Flow
+$89.7M
Cap. Flow %
22.86%
Top 10 Hldgs %
58.69%
Holding
189
New
48
Increased
30
Reduced
62
Closed
47

Top Sells

Rank Stock Value
1
SKT icon
Tanger
SKT
+$3.39M
2
CPRI icon
Capri Holdings
CPRI
+$3.29M
3
PLCE icon
Children's Place
PLCE
+$3.19M
4
DHIL
Diamond Hill
DHIL
+$2.37M
5
WW
WW International
WW
+$1.88M

Sector Composition

Rank Sector Weight
1 Industrials 6.83%
2 Consumer Discretionary 6.06%
3 Technology 5.36%
4 Financials 5.07%
5 Materials 4.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPRI icon
51
Capri Holdings
CPRI
$1.75B
$1.59M 0.4%
37,779
-107,620
-74% -$3.29M
WW
52
DELISTED
WW International
WW
$1.58M 0.4%
64,927
-72,311
-53% -$1.88M
PARA
53
DELISTED
Paramount Global Class B
PARA
$1.54M 0.39%
41,234
-40,126
-49% -$1.29M
HYRE
54
DELISTED
HyreCar Inc. Common Stock
HYRE
$1.53M 0.39%
214,674
-49,284
-19% -$270K
CLS icon
55
Celestica
CLS
$36.2B
$1.52M 0.39%
188,816
+47,682
+34% +$349K
C icon
56
Citigroup
C
$227B
$1.5M 0.38%
24,388
-125
-0.5% -$6.35K
CMTL icon
57
Comtech Telecommunications
CMTL
$51.5M
$1.5M 0.38%
+72,281
New +$1.26M
LEA icon
58
Lear
LEA
$8.05B
$1.48M 0.38%
9,270
-3,435
-27% -$483K
PRTH icon
59
Priority Technology Holdings
PRTH
$431M
$1.42M 0.36%
201,382
+67,783
+51% +$290K
SPOK icon
60
Spok Holdings
SPOK
$237M
$1.38M 0.35%
124,322
+55,652
+81% +$549K
STR
61
DELISTED
Sitio Royalties
STR
$1.37M 0.35%
+108,750
New +$1.1M
PLPC icon
62
Preformed Line Products
PLPC
$2.26B
$1.36M 0.35%
19,877
+4,684
+31% +$271K
TESS
63
DELISTED
Tessco Technologies Inc
TESS
$1.27M 0.32%
203,999
-39,377
-16% -$235K
SBH icon
64
Sally Beauty Holdings
SBH
$1.57B
$1.26M 0.32%
+96,659
New +$1.03M
IRIX icon
65
IRIDEX
IRIX
$14.7M
$1.26M 0.32%
500,817
+59,407
+13% +$112K
GS icon
66
Goldman Sachs
GS
$301B
$1.21M 0.31%
4,573
-2,592
-36% -$577K
CXT icon
67
Crane NXT
CXT
$2.96B
$1.18M 0.3%
+43,712
New +$963K
SRTS icon
68
Sensus Healthcare
SRTS
$50.9M
$1.17M 0.3%
303,766
+86,139
+40% +$263K
CAH icon
69
Cardinal Health
CAH
$55.5B
$1.13M 0.29%
21,120
-24,241
-53% -$1.26M
HWCC
70
DELISTED
Houston Wire & Cable Company
HWCC
$1.12M 0.29%
400,733
+31,908
+9% +$86.7K
TROX icon
71
Tronox
TROX
$993M
$1.05M 0.27%
+71,783
New +$835K
NTUS
72
DELISTED
Natus Medical Inc
NTUS
$1.01M 0.26%
+50,252
New +$984K
HRTG icon
73
Heritage Insurance Holdings
HRTG
$990M
$960K 0.24%
+94,782
New +$974K
VHI icon
74
Valhi
VHI
$474M
$936K 0.24%
61,572
+5,192
+9% +$78.1K
SKT icon
75
CALL
Tanger
SKT
$4.44B
$933K 0.24%
93,700
-371,700
-80% -$3.14M

Similar funds

Invenomic Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, Invenomic Capital Management held 189 positions worth $392M, up 116% from $182M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Invenomic Capital Management deployed $89.7M of net new capital in Q4 2020, opening 48 new positions and adding to 30 existing holdings. Its largest new stake was China Mobile Limited: 154,826 shares worth $4.42M.

By sector, the portfolio is most concentrated in Industrials at 6.8% of assets, down from 10% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Tanger, an estimated $3.39M trimmed.

  • Invenomic Capital Management's largest Q4 2020 buy was China Mobile Limited: 154,826 shares worth $4.42M.
  • Invenomic Capital Management added most to Kinross Gold in Q4 2020, an estimated $3.92M increase.
  • Invenomic Capital Management's biggest Q4 2020 reduction was Tanger, cutting an estimated $3.39M.
  • Invenomic Capital Management fully exited F5 in Q4 2020, selling an estimated $1.62M.
  • Invenomic Capital Management's ten largest holdings make up 59% of its $392M portfolio in Q4 2020.
  • Invenomic Capital Management opened 48 new positions and closed 47 in Q4 2020.
  • Invenomic Capital Management's portfolio value rose 116% quarter-over-quarter to $392M.

Based on Invenomic Capital Management's 13F filing for Q4 2020, filed 17 Feb 2021.